Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
Tickers FULC NEWS RHHBY RNA
Tags Benzinga General Upgrades
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags TAK General why it's moving
From Benzinga
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
Tickers BNTX MRK MRNA NEWS
Tags MRK Biotech AI Generated
From Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Tickers ABT BVNKF BVNRY DGX
Tags Top Stories Media Benzinga
From Benzinga
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
Tickers LLY NVO RHHBY
Tags Recent Press Releases LLY RHHBY
From Motley Fool
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
Tickers LLY NEWS NVO RHHBY
Tags NVO Market News Briefs
From Benzinga
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
Tickers NEWS RHHBY TPST
Tags News TPST Health Care
From Benzinga
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
Tickers LLY NVO RHHBY
Tags LLY Recent Press Releases Market News
From Motley Fool
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
Tickers ABBV BMY NEWS RHHBY
Tags ABBV Biotech RHHBY
From Benzinga
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
Tickers MRK NEWS RHHBY
Tags Briefs Biotech RHHBY
From Benzinga
Here's Why Eli Lilly Stock Dropped 12% Last Month
Tickers AMGN LLY NVO PFE
Tags NVO RHHBY Market News
From Motley Fool
Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions
Tickers C GOOG GOOGL NEWS
Tags GOOGL Briefs C
From Benzinga
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
Tickers AGEN BMY MRK NEWS
Tags Large Cap News Health Care
From Benzinga
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
Tickers ALT LLY NVO PFE
Tags RHHBY NVO Market News
From Motley Fool
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
Tickers LLY NVO RHHBY
Tags Market News RHHBY NVO
From Motley Fool
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Tickers LLY NEWS NVO PFE
Tags Health Care LLY News
From Benzinga
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
Tickers LLY NVO RHHBY
Tags Recent Press Releases LLY RHHBY
From Motley Fool
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
Tickers LLY NEWS NVO PFE
Tags Market News NVO Briefs
From Benzinga
This Big Pharma Could Become a Leading Weight-Loss Stock. Should You Buy It?
Tickers RHHBY
Tags Market News RHHBY Recent Press Releases
From Motley Fool
Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche
Tickers PFE RHHBY
Tags Recent Press Releases Market News PFE
From Motley Fool
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Tickers AMGN AZN HRTS LLY
Tags HRTS weight/loss drugs Exclusives
From Benzinga
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
Tickers AA ABT ALK BX
Tags DPZ CTAS NFLX
From Benzinga
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
Tickers LLY NVO RHHBY
Tags Market News RHHBY NVO
From Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
Tickers LLY NEWS NVO PFE
Tags Benzinga General contributors
From Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
Tickers GPCR LLY NEWS NVO
Tags VKTX GPCR RHHBY
From Benzinga
Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study
Tickers NEWS RHHBY
Tags Health Care Eurasia Large Cap
From Benzinga
3 Small-Cap Stocks With Explosive 2X Growth Potential
Tickers AMGN BAYRY CHPT EXAI
Tags Stocks to Buy VRDN CHPT
From InvestorPlace
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
Tickers MRK NEWS RHHBY
Tags Market News Briefs News
From Benzinga
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
Tickers ABBV BNTX GMAB JNJ
Tags BNTX Market News JNJ
From Benzinga
Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
Tickers AZN GEHC JNJ NEWS
Tags Stories That Matter RHHBY AZN
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
   
Privacy Policy  |  Terms of Use  |  MNG Corporate Site Map  |  Copyright